Johnson & Johnson continues to fight lawsuits linking talc-based powder to cancer

In February, Johnson & Johnson was ordered to pay $72 million to the family of a woman died of ovarian cancer linked to the company’s talc-based powders. Still, Johnson & Johnson maintains the safety of its products, according to a recent Reuters article.

Advertisement

Gene Williams, a lawyer representing the company, recently told Reuters there is “no proven linkage between talc and ovarian cancer, and the vast majority of scientific and regulatory bodies, who have reviewed the same studies the plaintiffs point to, do not accept the premise.”

Despite the company’s claims, more than 1,400 cases have been filed over the safety of Johnson & Johnson’s Baby Powder and Shower to Shower products. According to the recent report, two of the cases have been scheduled for this fall.

 

 

More articles on industry lawsuits:
11 latest healthcare industry lawsuits, settlements
House Republicans prevail in lawsuit over ACA cost-sharing subsidies
Lawsuit: Portland Adventist forcibly removed disabled vet because of service dog

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Download Whitepaper

The cost-saving opportunity most health systems overlook

Many hospitals and health systems scrutinize staffing, service lines, and payer contracts for savings. Fewer look at one of their largest assets: real estate.…

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.